Cite
HARVARD Citation
Sasaki, K. et al. (2021). Prognostic factors for progression in patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia in complete molecular response within 3 months of therapy with tyrosine kinase inhibitors. Cancer. 127 (15), pp. 2648-2656. [Online].